F
Forever Young Pharmacy
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | A | 5 | 7.4 | 6.3 | 8.5 | 17 Dec 2024 |
| BPC-157 | B | 5 | 7.2 | 5.6 | 9.5 | 17 Dec 2024 |
| Tirzepatide | B | 3 | 6.9 | 5.8 | 8.0 | 2 Apr 2025 |
| CJC-1295 | C | 5 | 6.9 | 5.0 | 8.9 | 17 Dec 2024 |
| Retatrutide | E | 8 | 2.9 | 1.5 | 7.1 | 17 Dec 2024 |
| 17a-Methyl-1-Testosterone | A | 2 | 5.2 | 4.7 | 5.6 | 25 May 2026 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | X | 1 | 7.7 | 7.7 | 7.7 | 3 Jun 2025 |
| 5-amino-1MQ Oral | A | 2 | 6.5 | 4.7 | 8.3 | 26 Jan 2026 |
| AA Water | A | 2 | 5.0 | 4.9 | 5.0 | 25 May 2026 |
| Abaloparatide | A | 2 | 6.8 | 6.1 | 7.4 | 24 May 2026 |
| ACE-031 | A | 2 | 5.3 | 4.3 | 6.4 | 21 May 2026 |
| Adipotide | A | 2 | 5.8 | 4.6 | 6.9 | 24 May 2026 |
| Anavar (Oxandrolone) | A | 2 | 5.7 | 4.3 | 7.1 | 26 Jan 2026 |
| BMK ethyl glycidate CAS 41232-97-7 | X | 1 | 5.1 | 5.1 | 5.1 | 8 Jul 2025 |
| CJC-1295 With DAC | X | 1 | 5.3 | 5.3 | 5.3 | 7 May 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | A | 2 | 6.9 | 5.7 | 8.2 | 21 May 2026 |
| Dapoxetine | X | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 |
| Estradiol Cypionate | X | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 |
| GW-501516 (Cardarine) | X | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 |
| HMG | A | 2 | 6.8 | 4.5 | 9.2 | 21 May 2026 |
| Hyaluronic acid | A | 2 | 4.0 | 3.1 | 3.8 | 23 May 2026 |
| IGF-1 LR3 | X | 1 | 4.0 | 3.2 | 3.2 | 21 May 2025 |
| KissPeptin-10 | A | 2 | 5.2 | 3.7 | 6.7 | 25 May 2026 |
| Lipo-C FOCUS 425mg | X | 1 | 7.2 | 7.2 | 7.2 | 11 Jun 2025 |
| MK-677 (Ibutamoren) Raw | X | 1 | 4.1 | 4.1 | 4.1 | 16 Mar 2025 |
| MOTS-C | A | 2 | 5.3 | 4.0 | 6.7 | 23 May 2026 |
| NA Semax Amidate | A | 2 | 5.2 | 3.4 | 7.1 | 19 Jan 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | A | 2 | 5.0 | 4.4 | 5.6 | 26 Jan 2026 |
| PE 22-28 | X | 1 | 6.3 | 6.3 | 6.3 | 13 Feb 2025 |
| PMK methyl glycidate CAS 1369021-80-6 | X | 1 | 8.4 | 8.4 | 8.4 | 6 May 2025 |
| Retatrutide 30mg Pen Kit | X | 1 | 4.0 | 2.2 | 2.2 | 3 Jun 2025 |
| Semax | X | 1 | 5.0 | 5.0 | 5.0 | 11 Jun 2025 |
| SNAP-8 | A | 2 | 5.1 | 4.6 | 5.6 | 17 May 2026 |
| Tesofensine | X | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 |
| Trenbolone Acetate Raw | A | 2 | 6.2 | 4.2 | 8.2 | 26 Jan 2026 |
| Trestolone Acetate (MENT) Raw | A | 2 | 4.8 | 2.3 | 7.2 | 24 May 2026 |
| Vilon | X | 1 | 8.8 | 8.8 | 8.8 | 28 Mar 2025 |
| Winstrol Water (Stanozolol) | X | 1 | 9.0 | 9.0 | 9.0 | 27 Feb 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | 17a-Methyl-1-Testosterone | 5.7 | 100mg | 123.9mg | +23.9% | 99.55% | Lab B |
| 25 May 2026 | Retatrutide 30mg Pen Kit | 4.0 | 10mg | 11.3mg | +12.6% | 96.88% | Lab B |
| 24 May 2026 | 5-amino-1MQ Oral | 5.6 | 20mg | 23.2mg | +16.2% | 98.52% | Lab D |
| 24 May 2026 | AA Water | 4.3 | 30mg | 28.9mg | -3.8% | 98.89% | Lab D |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.8 | 20mg | 18.2mg | -9.2% | 99.57% | Lab F |
| 24 May 2026 | Dapoxetine | 4.6 | 10mg | 8.9mg | -11.3% | 99.24% | Lab B |
| 24 May 2026 | Anavar (Oxandrolone) | 7.4 | 25mg | 28.7mg | +14.7% | 95.95% | Lab E |
| 24 May 2026 | KissPeptin-10 | 6.0 | 30mg | 30.2mg | +0.8% | 98.07% | Lab D |
| 24 May 2026 | Trenbolone Acetate Raw | 7.8 | 5g | 4.7g | -6.3% | 95.47% | Lab E |
| 24 May 2026 | Abaloparatide | 5.5 | 5mg | 6.2mg | +24.8% | 98.88% | Lab G |
| 24 May 2026 | Trenbolone Acetate Raw | 4.0 | 5g | 4.6g | -7.4% | 98.32% | Lab C |
| 24 May 2026 | SNAP-8 | 7.2 | 30mg | 29.1mg | -3.1% | 96.03% | Lab B |
| 23 May 2026 | 5-amino-1MQ Oral | 7.5 | 50mg | 59.1mg | +18.2% | 98.41% | Lab D |
| 23 May 2026 | MOTS-C | 4.8 | 20mg | 21.4mg | +6.8% | 98.09% | Lab C |
| 23 May 2026 | Adipotide | 5.9 | 15mg | 16.1mg | +7.6% | 97.11% | Lab E |
| 23 May 2026 | PE 22-28 | 4.8 | 10mg | 8.9mg | -10.9% | 97.79% | Lab B |
| 21 May 2026 | IGF-1 LR3 | 5.3 | 15mg | 16.9mg | +12.5% | 98.20% | Lab D |
| 19 May 2026 | AA Water | 4.0 | 50mg | 45.8mg | -8.4% | 97.58% | Lab D |
| 19 May 2026 | Tesofensine | 6.7 | 100mg | 90.3mg | -9.7% | 98.72% | Lab C |
| 17 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.0 | 50mg | 44.3mg | -11.4% | 99.90% | Lab G |
| 29 Jan 2026 | Estradiol Cypionate | 5.9 | 100mg/ml | 116.3mg/ml | +16.3% | 98.51% | Lab B |
| 29 Jan 2026 | MK-677 (Ibutamoren) Raw | 4.0 | 5g | 5.0g | -0.1% | 95.20% | Lab D |
| 29 Jan 2026 | Vilon | 9.0 | 10mg | 10.2mg | +2.2% | 97.70% | Lab D |
| 26 Jan 2026 | Abaloparatide | 9.3 | 10mg | 10.7mg | +7.1% | 98.48% | Lab D |
| 26 Jan 2026 | GW-501516 (Cardarine) | 5.8 | 100mg | 122.1mg | +22.1% | 95.64% | Lab D |
| 26 Jan 2026 | Lipo-C FOCUS 425mg | 9.7 | 250mg/ml | 268.2mg/ml | +7.3% | 96.06% | Lab F |
| 26 Jan 2026 | PMK methyl glycidate CAS 1369021-80-6 | 7.6 | 500g | 448.3g | -10.3% | 96.28% | Lab D |
| 19 Jan 2026 | KissPeptin-10 | 4.6 | 15mg | 15.3mg | +1.7% | 95.89% | Lab A |
| 19 Jan 2026 | MOTS-C | 6.4 | 15mg | 14.7mg | -1.8% | 97.30% | Lab G |
| 19 Jan 2026 | Winstrol Water (Stanozolol) | 9.9 | 200mg/ml | 189.8mg/ml | -5.1% | 99.34% | Lab D |
| 9 Jan 2026 | CJC-1295 With DAC | 6.2 | 5mg | 4.6mg | -8.5% | 95.53% | Lab G |
| 9 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.9 | 5mg | 5.6mg | +12.5% | 97.45% | Lab E |
| 9 Jan 2026 | Trestolone Acetate (MENT) Raw | 4.7 | 5g | 4.4g | -11.4% | 96.36% | Lab D |
| 7 Jan 2026 | Trestolone Acetate (MENT) Raw | 4.0 | 10g | 9.2g | -8.5% | 97.31% | Lab D |
| 6 Jan 2026 | NA Semax Amidate | 6.5 | 30mg | 25.6mg | -14.6% | 99.97% | Lab A |
| 6 Jan 2026 | Semax | 4.2 | 2mg | 2.0mg | -2.5% | 95.93% | Lab E |
| 12 Dec 2025 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 10.0 | 5g | 5.3g | +5.8% | 99.38% | Lab D |
| 12 Dec 2025 | Anavar (Oxandrolone) | 5.8 | 100mg | 91.7mg | -8.3% | 98.79% | Lab F |
| 5 Dec 2025 | ACE-031 | 5.2 | 50mg | 50.5mg | +1.1% | 95.72% | Lab C |
| 23 Nov 2025 | 17a-Methyl-1-Testosterone | 4.6 | 100mg | 117.8mg | +17.8% | 98.04% | Lab C |
| 23 Nov 2025 | ACE-031 | 5.6 | 30mg | 26.8mg | -10.8% | 99.65% | Lab A |
| 23 Nov 2025 | HMG | 7.7 | 50mg | 52.1mg | +4.1% | 99.83% | Lab A |
| 17 Nov 2025 | NA Semax Amidate | 4.5 | 20mg | 19.6mg | -1.8% | 99.48% | Lab C |
| 17 Nov 2025 | SNAP-8 | 4.0 | 20mg | 24.6mg | +23.2% | 98.30% | Lab B |
| 14 Nov 2025 | BMK ethyl glycidate CAS 41232-97-7 | 7.2 | 10g | 12.4g | +24.4% | 99.84% | Lab B |
| 5 Nov 2025 | HMG | 5.6 | 5mg | 6.0mg | +20.0% | 95.24% | Lab G |
| 5 Nov 2025 | Hyaluronic acid | 5.5 | 20mg | 20.0mg | +0.2% | 96.87% | Lab G |
| 4 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.3 | 20mg | 24.9mg | +24.4% | 96.30% | Lab G |
| 17 Oct 2025 | Hyaluronic acid | 5.0 | 10mg | 10.2mg | +2.4% | 99.12% | Lab D |
| 9 Oct 2025 | Adipotide | 6.2 | 2mg | 2.3mg | +13.1% | 99.77% | Lab A |
| 2 Apr 2025 | Tirzepatide | 8.0 | 30mg | (no batch claim) | 29.04mg | (no batch ID) | |
| 2 Apr 2025 | Tirzepatide | 5.8 | 15mg | (no batch claim) | 15.5mg | (no batch ID) | |
| 2 Apr 2025 | Tirzepatide | 6.8 | 15mg | (no batch claim) | 13.69mg | (no batch ID) | |
| 28 Mar 2025 | Retatrutide | 3.9 | 20mg | (no batch claim) | 22.28mg | (no batch ID) | |
| 21 Feb 2025 | CJC-1295 | No DAC | 5.0 | 5mg | 5.5mgpackage | 6.17mg | 22470 |